Revance Therapeutics Inc RVNC:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:27 AM EDT
4.95quote price arrow up+0.01 (+0.20%)
Volume
125
Close
4.94quote price arrow up+0.24 (+5.11%)
Volume
1,362,285
52 week range
4.57 - 37.98
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.94
  • 52 Week High37.98
  • 52 Week High Date05/09/23
  • 52 Week Low4.57
  • 52 Week Low Date03/25/24

Key Stats

  • Market Cap514.825M
  • Shares Out104.22M
  • 10 Day Average Volume1.67M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-43.8

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.94
  • 52 Week High37.98
  • 52 Week High Date05/09/23
  • 52 Week Low4.57
  • 52 Week Low Date03/25/24
  • Market Cap514.825M
  • Shares Out104.22M
  • 10 Day Average Volume1.67M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-43.8

RATIOS/PROFITABILITY

  • EPS (TTM)-3.81
  • P/E (TTM)-1.30
  • Fwd P/E (NTM)-2.00
  • EBITDA (TTM)-207.032M
  • ROE (TTM)-2,096.78%
  • Revenue (TTM)234.04M
  • Gross Margin (TTM)68.23%
  • Net Margin (TTM)-138.43%
  • Debt To Equity (MRQ)-284.79%

EVENTS

  • Earnings Date05/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Revance Therapeutics Inc

 

Profile

MORE
Revance Therapeutics, Inc. is a biotechnology company. The Company is focused on advanced aesthetic and therapeutic offerings. The Company’s aesthetics portfolio of expertly created products and services, including DAXXIFY (DaxibotulinumtoxinA-lanm) for injection, the RHA Collection of dermal fillers, and OPUL, the first-of-its-kind relational commerce platform for aesthetic practices. The Company’s therapeutics pipeline is focused on muscle movement disorders, including...
Angus Russell
Independent Chairman of the Board
Mark Foley
Chief Executive Officer, Director
Dustin Sjuts
President
Tobin Schilke
Chief Financial Officer
Address
1222 Demonbreun Street, Suite 2000
Nashville, TN
37203
United States

Top Peers

SYMBOLLASTCHG%CHG
AKBA
Akebia Therapeutics Inc
2.24+0.24+12.00%
PBYI
Puma Biotechnology Inc
5.58-0.02-0.36%
ADPT
Adaptive Biotechnologies Corp
2.89+0.01+0.35%
CHRS
Coherus BioSciences Inc
2.42+0.12+5.22%
ME
23andMe Holding Co.
0.5104+0.0226+4.633%